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ABSTRACT 
Determining the mechanisms by which membrane targeted dietary bioactives reduce oncogenic 
KRas driven nutrient scavenging 
 
Michael Lee Salinas 
Department of Nutrition & Food Science 
Texas A&M University 
 
Research Advisor: Dr. Robert S. Chapkin 
Department of Nutrition & Food Science 
 
Approximately 30 to 50% of colorectal cancers contain KRas mutations, which confer resistance 
to standard therapy and have therefore been termed “undruggable.”  Since no curative treatments 
for KRas driven colon cancer are available, there is a critical need to develop toxicologically 
innocuous KRas therapeutic approaches that are free of safety problems intrinsic to drugs 
administered over long periods of time.  The present study will investigate the mechanisms 
underlying previous observations that membrane targeted dietary bioactives (MTDBs) attenuate 
oncogenic Ras driven nutrient scavenging.  The overall goal of the study is to link perturbations 
in plasma membrane organization and cytoskeletal remodeling to reductions in macropinocytosis 
and ultimately cell proliferation.  For this purpose, we have utilized a human colon 
adenocarcinoma cell line as an in vitro model.  These experiments are relevant to the 
chemoprevention field, i.e., colorectal cancer prevention. 
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NOMENCLATURE 
 
DHA   Docosahexaenoic Acid 
DPBS   Dulbecco's Phosphate Buffered Saline 
EIPA   5-(N-ethyl-N-isopropyl)amiloride 
EPA   Eicosapentaenoic Acid 
FBS   Fetal Bovine Serum 
FITC   Fluorescein Isothiocyanate 
FOV   Field of View 
GP   Generalized Polarization 
LSD   Least Significant Difference 
MTDB   Membrane Targeted Dietary Bioactives 
MW   Molecular Weight 
n-3 PUFA  Omega-3 Polyunsaturated Fatty Acids 
PBS   Phosphate Buffered Saline 
TMR   Tetramethlyrhodamine 
UV   Ultraviolet 
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CHAPTER I  
INTRODUCTION 
 
Colorectal cancer is one of the major causes of death from cancer in the United States and 
around the globe (Jemal et al., 2011).  Ras mutations are found in three out of the four most 
lethal types of cancer which are the colon, lung, and pancreatic cancer (Cox et al, 2014).  There 
are three Ras isoforms H-, N-, and KRas, with the latter being the most common in colon cancer.  
Recently, Ras had been termed “undruggable” due to no effective pharmacological inhibitors 
reaching clinical studies (Cox et al., 2014).  Although direct pharmacological drugs had been 
shown to be ineffective, targeting the Ras driven dependencies may be a viable strategy 
(Commisso et al., 2013).  
 
Substantial evidence exists that long chain n-3 PUFA, e.g. docosahexaenoic acid (DHA) and 
eicosapentaenoic acid (EPA), are chemoprotective agents which protect against colon 
tumorigenesis (Reddy et al., 2005; Chapkin et al., 2014).  Furthermore, other dietary compounds 
such as curcumin, and walnut-derived procyanidins appear to exhibit chemoprotective properties 
(Park et al., 2013; Falasca et al., 2014).  Interestingly these dietary compounds are known to 
influence the biophysical properties of plasma membranes (Erlejman et al., 2004; Kim et al., 
2008; Tsukamoto et al., 2014).  This is noteworthy because the biophysical properties of the 
membrane lipid bilayer are known to influence many cell signaling events (Nicolson, 2014).  
Therefore, we propose that these dietary compounds fall into a unique class of membrane 
targeted dietary bioactives (MTDBs) that influence aspects of cellular signaling through direct 
perturbation of plasma membrane organization.   
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KRas driven oncogenic proliferation is dependent on the uptake of extracellular lipids and 
proteins to be used as fuel in the process termed macropinocytosis (Commisso et al., 2013; 
Salloum et al., 2014).  Since the biophysical properties of the plasma membrane can influence 
uptake of extracellular lipids and proteins (Magenau et al., 2011), we have hypothesized that 
MTDB modulation of the plasma membrane organization may underlie their ability to reduce 
macropinocytosis and therefore cancer cell related growth (Commisso et al., 2013). 
 
Objectives 
The purpose of the conducted experiments was to determine how membrane active dietary 
compounds influence the proliferation of KRas driven colon cancer.  Using plate reader assays, 
we have validated that n-3 PUFAs, curcumin, and procyanidins actively influence plasma 
membrane organization.  We initially determined the minimal effective dose of select MTDB 
compounds with respect to SW48 plasma membrane organization.  This is important because 
membrane organization is known to influence cellular processes (Nicolson, 2014). We 
subsequently determined how these dietary compounds alter macropinocytosis, since membrane 
organization and cytoskeletal remodeling are important steps regulating this process (Butler et 
al., 2013; Fujii et al., 2013).  Since KRas driven cancer cells are dependent on macropinocytosis 
for proliferation, we hypothesize that MTDB inhibition of KRas driven macropinocytosis is 
mediated by disruption of Rac1 activation and alterations in plasma membrane organization. 
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CHAPTER II 
METHODS 
 
Cell culture and treatments 
SW48 human colorectal adenocarcinoma cells (SW48-KRas-wild type (control) and SW48-
KRas-G12D engineered to express oncogenic KRas) were provided by Horizon Discovery, 
Cambridge, United Kingdom were utilized. The two cell lines were cultured at 37°C and 5% 
CO2 in the presence of 10% fetal bovine serum (FBS; Hyclone, Logan, UT) and 1% 
Penicillin/Streptomycin.  Select cultures were treated with physiologically relevant doses of 
MTDBs added to standard culture media for specific time intervals (Conquer et al., 1998; Kim et 
al., 2008; Irving et al., 2013; Verstraeten et al., 2013).  
 
Quantification of macropinocytosis  
Cells were seeded onto poly-L-lysine treated chamber slides.  Twenty-four to 48 hours after cells 
were seeded, cells were serum starved for 16-24 hours.  During the final hours of starvation, cells 
were treated with varying doses and combinations of MTDBs.  Cells were also treated with 5-(N-
ethyl-N-isopropyl)amiloride (EIPA), a macropinocytosis inhibitor specifically a Na+/H+ 
exchange inhibitor, utilized as our positive control of macropinocytosis (Commisso et al., 2013).  
After treatment, fluorescein isothiocyanate (FITC)-dextran 70,000 MW (1 mg/mL), CellMask 
Deep Red Plasma Membrane dye (1 µL/mL), and Hoechst 33342 (1 µg/mL) were added to the 
cell media.  Cells were incubated with the dyes for 30 minutes at 37°C.  At the end of the 
incubation and starvation period, cells were placed on ice, rinsed five times with ice cold PBS 
and fixed in 4% paraformaldehyde for 10-30 minutes.  To complete the macropinocytosis assay, 
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cells were imaged using fluorescent microscopy.  Cell images were then analyzed and quantified 
using ImageJ software (Commisso et al., 2013; Commisso et al., 2014).  Adapted from a Nature 
protocol, a macro was created to determine the macropinocytic index (Commisso et al., 2014).  
The total cell area is determine by a threshold set according to the plasma membrane dye 
channel.  The total macropinosome area was identified by subtracting the background from the 
FITC-dextran dye channel, and setting a threshold for the relative size of the puncta.  The 
macropinocytic index was calculated by the division of the total macropinosome area by the total 
cell area then multiplied by 100. 
 
Quantification of cell proliferation 
Cell proliferation was monitored by CyQUANT Direct Cell Proliferation Assay (ThermoFisher, 
Waltham, MA).  Cells were seeded in 96-well plates, and treated with curcumin (1 µM, 10 µM, 
and 50 µM), (+)-catechin (25 µM, and 50 µM), and procyanidin B2 (25 µM, and 50 µM).  The 
proliferation assay was performed according to the manufacturer’s instructions.  The 
fluorescence signal was monitored and recorded every other day for seven days. Cell media was 
replaced with new treated media on the third day and every other day after. 
 
Quantification of cell viability 
Cell viability was assessed using LIVE/DEAD Cell Viability Assay Kit (ThermoFisher, 
Waltham, MA).  Cells were seeded in 96-well plates and treated with MTDBs.  Cells were 
treated for seven days, and new treated media was added every other day.  C12 resazurin and 
SYTOX Green from the LIVE/DEAD Cell Viability Assay Kit (ThermoFisher, Waltham, MA) 
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were added to each well according to the manufacturer’s instructions.  After 15 minutes of 
incubation, the cells viability was measured by fluorescent microscopy. 
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CHAPTER III 
RESULTS 
 
Macropinocytosis 
Because select MTDBs modify membrane organization (Holy, 2004; Magenau et al., 2011), we 
expected to see an inhibition of macropinocytosis upon exposure to MTDBs.  Certain SW48 
cells treated with curcumin (1 µM, 10 µM, or 50 µM), (+)-catechin (25 µM, or 50 µM), or 
procyanidin B2 (25 µM, or 50 µM) for one hour exhibited a reduction in FITC-dextran uptake 
illustrating a reduction in macropinocytosis. 
 
Figure 1. Macropinocytosis and macropinosomes.  SW48 cell’s nuclei were stained with 
Hoechst and can be seen in blue.  TMR-dextran was taken up by the SW48 cells through 
macropinocytosis and are in macropinosome vesicles seen in red.  Macropinosomes are then set 
to appropriate thresholds and surface area. 
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Figure 2. MTDBs inhibit macropinocytosis.  SW48 cells were treated with 100 nM EIPA, 
curcumin (1 µM, 10 µM, or 50 µM), (+)-catechin (25 µM, or 50 µM), or procyanidin B2 (25 
µM, or 50 µM) for one hour.  FITC-dextran absorption was utilized to determine 
macropinocytosis uptake.  Cells were imaged using a 40X objective on a TE 300 Nikon Eclipse 
fluorescence microscope.  n=15 separate FOV (~300 cells) for each group from 1 experiment. 
Statistical significance was measured using Fisher’s Protected Least Significant Difference 
(LSD) test. 
 
Curcumin has been known to autofluoresce when excited with UV-light and can fluoresce or 
crosstalk or bleedthrough to the FITC-channel (Chignell et al., 1994).  This crosstalk is what lead 
to the apparent increase of “macropinosome” signal. 
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Cell proliferation 
Multiple concentrations of MTDBs reduced G12D mutated SW48 human colorectal 
adenocarcinoma cell proliferation (Figure 3).  The concentrations of MTDBs were selected 
based on human blood levels and levels of MTDBs in the human colonic mucosa (Conquer et al., 
1998; Kim et al., 2008; Irving et al., 2013; Verstraeten et al., 2013). 
 
Figure 3. MTDBs reduce proliferation of SW48-Kras-G12D cells.  SW48 cells were treated 
with curcumin (1 µM, 10 µM, and 50 µM), (+)-catechin (25 µM, and 50 µM), or procyanidin B2 
(25 µM, and 50 µM) for 7 days.  Media was changed on days 3, 5 and 7 with fresh treated 
McCoy’s media.  CyQUANT Direct Cell Proliferation Assay was utilized to quantify cell counts 
using a fluorescence microplate reader.  n=12 separate wells for each group from 1 experiment.  
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Cell Viability 
Curcumin at 1 µM, 10 µM and 50 µM had no effect on cell viability after one hour of treatment 
(Figure 4).  Similarly, curcumin (1 µM, and 10 µM), (+)-catechin (25 µM, and 50 µM), and 
procyanidin B2 (25 µM, and 50 µM) had no effect on cell viability after seven days of treatment.  
Curcumin at 50 µM reduced SW48-KRas-G12D cell viability after seven days.   
  
 
Figure 4. Curcumin exhibited no effect on cell viability.  SW48 cells were treated with 
curcumin (1 µM, 10 µM, and 50 µM) for one hour.  LIVE/DEAD Cell Viability Assay Kit was 
utilized to determine cell viability.  Cells were imaged using a 10X objective on a TE 300 Nikon 
Eclipse fluorescence microscope.  n=3 separate FOV (~1,200 cells) for each group from 1 
experiment.  
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Figure 5. MTDBs exhibited no effect on cell viability.  SW48 cells were treated with curcumin 
(1 µM, 10 µM, and 50 µM), (+)-catechin (25 µM, and 50 µM), or procyanidin B2 (25 µM, and 
50 µM) for seven days.  LIVE/DEAD Cell Viability Assay Kit was utilized to determine cell 
viability.  Cells were imaged using a 10X objective on a TE 300 Nikon Eclipse fluorescence 
microscope.  n=3 separate FOV (~1,000 cells) for each group from 1 experiment. 
 
15 
 
 
CHAPTER IV 
CONCLUSION 
 
Curcumin, (+)-catechin, and procyanidin B2 have previously been shown to modify plasma 
membrane signaling and fluidity (Erlejman et al., 2004; Park et al., 2013; Falasca et al., 2014; 
Tsukamoto et al., 2014).  Upon incubation of SW48 human colorectal adenocarcinoma cells with 
MTDBs, macropinocytosis was inhibited and proliferation was reduced.  Our data demonstrate 
that amphiphilic molecules such as (+)-catechin are capable of modifying KRas-driven 
macropinocytosis (Figure 2).  Since macropinocytosis plays a vital role in the uptake of amino 
acids and lipids for KRas-dependent cancers, inhibition of macropinocytosis leads to a reduction 
in cellular growth and proliferation (Commisso et al., 2013; White, 2013).  Our findings suggest 
the ability of (+)-catechin to suppress Ras membrane signaling may be linked to the reduction of 
macropinocytosis.  It is important to further determine the mechanism by which these MTDBs 
modulate plasma membrane signaling, so that the role of MTDBs can be assessed with regard to 
mutant KRas inhibition. 
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APPENDIX A 
FUTURE EXPERIMENTS 
 
Quantification of plasma membrane order 
The organization of the plasma membrane was monitored by fluorescence spectroscopy of the 
polarity sensitive dye Di-4-ANEPPDHQ as previously described (Owen et al., 2012).  Briefly, 5 
µM of Di-4-ANEPPDHQ will be added to SW48 cells in 96-well plates, and immediately 
analyzed.   Generalized polarization (GP) was calculated by obtaining the emission intensity (I) 
from the ordered (510-550 nm) and disordered (650-700 nm) when excited at 488 nm and 
applying the following equation: 
GP = (I(510-550) – I(650-700))/(I(510-550) + I(650-700)) 
Cells were imaged using a fluorescence microplate reader (CLARIOstar, BMG LABTECH, 
Cary, NC). 
 
Quantification of active Rac1 
Activation of Rac1 will be determined using a kit from Cytoskeleton (Denver, CO) as we have 
described previously (Turk et al., 2013).  Briefly, samples for these assays will be harvested as 
described above using the lysis buffer provided and supplemented with protease and phosphatase 
inhibitors (Sigma).  Activation of Cdc42 and Rac1 will be analyzed using G-LISA Cdc42 and 
Rac1 Activation Assay Biochem kits, respectively, in the colorimetric format.  The assays will 
be performed using 25 µg of cell protein according to the manufacturer’s instructions.  
Absorbance will be measured using a microplate reader (SpectraMax 190, Molecular Devices, 
Sunnyvale, CA). 
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Quantification of macropinocytosis using MTDB combinations 
A combination of MTDBs at effectively low doses will be utilized to assess the synergistic 
effects on macropinocytosis inhibition.  The methods utilized will be the same as the prior 
macropinocytosis experiments that we conducted (described above).  Previous data from our lab 
have shown synergistic effects on outcomes when treated with a combination of extrinsic factors 
such as MTDBs (Kolar et al., 2007; Turk et al., 2011; Chapkin et al., 2014; Triff et al., 2015). 
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APPENDIX B 
PROTOCOL: CELL SEEDING AND FEEDING 
 
Purpose: To seed SW48 cells for macropinocytosis, proliferation, and viability assays. 
Materials:  
 Complete McCoy’s 5A Media 
 Trypsin 
 1X DPBS 
 T-75 flask 
 50 mL conical tube 
 (2) 15 mL conical tube 
 Plastic pipettes 
 Glass pipettes 
 Vacuum aspirator 
 37°C/5% CO2 cell culture incubator 
Procedure:  
1. Sterilize the hood. 
2. Aliquot 50 mL of McCoy’s media into a 50 mL conical tube.  Warm media to 37°C. 
3. Aliquot 6 mL of trypsin into a 15 mL conical tube.  Warm trypsin to 37°C. 
4. Open the T-75 flask under the hood using sterile techniques. 
5. Aspirate media from flask.  Wash with 10 mL of sterile 1X DPBS.  Aspirate DPBS. 
6. Add 5 mL trypsin and incubate at 37°C for 5 minutes. 
7. Add 10 mL of warm media into the flask to stop trypsinization.  Transfer trypsinized cells 
into a sterile 15mL conical tube to spin down cells. 
8. Centrifuge the cells in the tube at 200 x g in the tabletop centrifuge for 5 minutes. 
9. After completion of the spin, aspirate supernatant to remove the media and trypsin from 
the cells and leave cell pellet. 
10. Resuspend the pellet in 5 mL of warm media. 
11. Open a new sterile T-75 flask under the hood using sterile techniques. 
12. Add 10 mL of warm media into the T-75 flask. 
13. Count the cells and seed approximately 2 x 106 cells into the T-75 flask.  Cell number 
needed varies per assay.  Need approximately 1 x 106 cells per chamber for 
macropinocytosis assay, approximately 1 x 105 cells per well for viability assay, and 
approximately 1 x 104 cells per well for proliferation assay.  Adjust for cell growth rate 
and size. 
14. Add the resuspended cells to the T-75 flask and rotate it gently to distribute the cells 
evenly. 
15. Label the flask.  Specify the cell type, passage number, date, and initials. 
16. Incubate the flask at 37°C under 5% CO2 atmospheric pressure. 
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APPENDIX C 
PROTOCOL: MACROPINOCYTOSIS ASSAY 
 
Purpose: To determine macropinocytosis in SW48 cells 
Materials:  
 Complete McCoy’s 5A Media 
 McCoy’s 5A Media (0% FBS) 
 70 kDa FITC-Dextran 
 5-(N-ethyl-N-isopropyl) amiloride (EIPA) 
 CellMask Deep Red Plasma Membrane dye 
 Hoechst 33342 dye 
 Poly-L-lysine 
 Paraformaldehyde (PFA) 
 Glycine 
 Curcumin 
 (+)-Catechin 
 Procyanidin B2 
 PBS 
 1X DPBS 
 Chambered slides 
 Plastic pipettes 
 Glass pipettes 
 Vacuum aspirator 
 37°C/5% CO2 cell culture incubator 
 40X objective  
 fluorescence microscope (TE 300 Nikon Eclipse) 
Procedure (Prior to assay):   
1. Sterilize the hood. 
2. Aseptically coat chamber slides or other cell culture surface with 1 mL/25cm2.  Rotate it 
gently to ensure even coating of the surface. 
3. After 5 minutes, remove the solution by aspiration and thoroughly rinse the surface with 
sterile water. 
4. Allow to dry for at least 2 hours before introducing cells or media. 
5. Seed appropriate number cells in the necessary number of chamber slides using sterile 
cell culture techniques. 
6. Incubate slides at 37°C under 5% CO2 atmospheric pressure. 
7. Serum starve cells 16 to 24 hours before continuing with assay. 
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Procedure: 
1. Aspirate serum free media from chamber slides. 
2. Add 500 µL of serum free media (negative control), 100 nM EIPA (positive control), 
curcumin (1 µL, 10 µL, or 50 µL), (+)-catechin (25 µL, or 50 µL), or procyanidin B2 (25 
µL, or 50 µL) treated media to respective cells in the chambers.  
3. Incubate at 37°C under 5% CO2 atmospheric pressure for 1 hour. 
4. After 1 hour of incubation, aspirate media and replace with 500 µL of media containing 
dyes.  One mg/mL FITC-dextran, 1 µL/mL CellMask Deep Red Plasma Membrane dye, 
and 1 µg/mL Hoechst 33342.  For the EIPA treated cells, EIPA needs to be present in the 
dye media at a concentration of 100nM. 
5. Incubate at 37°C under 5% CO2 atmospheric pressure for 30 minutes. 
6. After 30 minutes of incubation, place cells on ice. 
7. Aspirate media and wash with ice cold PBS 5 times. 
8. Add 500 µL of 4% PFA to each chamber for 10 minutes. 
9. Wash with PBS 2 times.  Add 500 µL of 100 mM glycine for 10 minutes. 
10. Wash with PBS 2 times.  Add 1 mL of DPBS to each chamber. 
11. Cells can be imaged or stored at 4°C.  Images were taken with a 40X objective on a TE 
300 Nikon Eclipse fluorescent microscope. 
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APPENDIX D 
PROTOCOL: CELL PROLIFERATION ASSAY 
 
Purpose: To determine SW48 cell proliferation. 
Materials:  
 Complete McCoy’s 5A Media 
 McCoy’s 5A Media (0% FBS) 
 5-(N-ethyl-N-isopropyl) amiloride (EIPA) 
 Curcumin 
 (+)-Catechin 
 Procyanidin B2 
 CyQUANT Direct Cell Proliferation Assay Kit 
o CyQUANT Direct nucleic acid stain 
o CyQUANT Direct background suppressor I 
 1X PBS 
 15 mL conical tube 
 96-well microplate(s) 
 Plastic pipettes 
 37°C/5% CO2 cell culture incubator 
 Microplate reader (CLARIOstar microplate reader) 
Procedure:  
1. Prepare 12 mL of 2X detection reagent, which is sufficient for 100 μL/well in a 96-well 
plate. 
2. Combine the following in 15 mL conical tube and mix well: 11.7 mL of 1X PBS, or cell 
culture media, 48 µL of CyQUANT Direct nucleic acid stain, and 240 µL of CyQUANT 
Direct background suppressor I. 
3. Add an equal volume of 2X detection reagent to cells in culture.  For example, add 100 
μL of 2X detection reagent to 100 µL of cells in cell culture media. 
4. Incubate cells with the detection reagent for 60 minutes at 37°C. 
5. Read fluorescence of samples using standard “green” or FITC filter sets or appropriate 
wavelengths (480/535 nm) if using a monochromatic instrument such as CLARIOstar 
microplate reader. 
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APPENDIX E 
PROTOCOL: CELL VIABILITY ASSAY 
 
Purpose: To determine SW48 cell viability. 
Materials:  
 Complete McCoy’s 5A Media 
 McCoy’s 5A Media (0% FBS) 
 5-(N-ethyl-N-isopropyl) amiloride (EIPA) 
 Curcumin 
 (+)-Catechin 
 Procyanidin B2 
 LIVE/DEAD Cell Viability Assay Kit 
o C12-Resazurin 
o SYTOX Green stain 
o Dimethylsulfoxide (DMSO), anhydrous 
o 10X Phosphate-buffered saline 
 96-well microplate(s) 
 Plastic pipettes 
 Glass pipettes 
 Vacuum aspirator 
 37°C/5% CO2 cell culture incubator 
 Microplate reader (CLARIOstar microplate reader) 
Procedure:  
1. Prepare a 1 mM stock solution of C12-resazurin.  Dissolve the contents of the vial of C12-
resazurin in 100 µL of DMSO.  Prepare a fresh 50 µM working solution of C12-resazurin 
by diluting 1 µL of the 1 mM C12-resazurin stock solution in 19 µL of DMSO.  
2. Prepare a 1 µM working solution of SYTOX Green stain.  Dilute 5 µL of the 10 µM 
SYTOX Green stain stock solution in 45 µL of DMSO. 
3. Prepare a 1X phosphate-buffered saline (PBS) solution.  Dilute 2 mL of the 10X PBS in 
18 mL of deionized water. 
4. Prepare a dye solution with a final concentration of 10 nM C12-resazurin and 5 µM 
SYTOX Green dye when added to cell media.  For example, dilute 1 µL of the 50 µM 
C12-resazurin working solution and 2 µL of the 1 µM SYTOX Green stain working 
solution to 200 µL of 1X PBS. 
5. Aspirate cell media and add 50 µL of the newly prepared dye solution to the wells. 
6. Incubate at 37°C under 5% CO2 atmospheric pressure for 15 minutes. 
7. Analyze the cell sample. As soon as possible, analyze the stained cells by microplate 
reader, exciting at 488 nm and measuring the fluorescence emission at 530 nm and 575 
nm.  
